FI20031455A0 - Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) - Google Patents
Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1)Info
- Publication number
- FI20031455A0 FI20031455A0 FI20031455A FI20031455A FI20031455A0 FI 20031455 A0 FI20031455 A0 FI 20031455A0 FI 20031455 A FI20031455 A FI 20031455A FI 20031455 A FI20031455 A FI 20031455A FI 20031455 A0 FI20031455 A0 FI 20031455A0
- Authority
- FI
- Finland
- Prior art keywords
- sstr4
- sstr1
- somatostatin receptor
- peptidomimetics
- sulfonylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20031455A FI20031455A0 (sv) | 2003-10-06 | 2003-10-06 | Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) |
US10/574,905 US20070129313A1 (en) | 2003-10-06 | 2004-10-05 | Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
JP2006530316A JP2007507472A (ja) | 2003-10-06 | 2004-10-05 | ソマトスタチン受容体サブタイプ4(sstr4)及び1(sstr1)に作用するスルホニルアミノ−ペプチド模倣薬 |
EP04767097A EP1678196B1 (en) | 2003-10-06 | 2004-10-05 | Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
AT04767097T ATE404580T1 (de) | 2003-10-06 | 2004-10-05 | Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken |
PCT/FI2004/000583 WO2005033124A1 (en) | 2003-10-06 | 2004-10-05 | Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1) |
DE602004015822T DE602004015822D1 (de) | 2003-10-06 | 2004-10-05 | Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20031455A FI20031455A0 (sv) | 2003-10-06 | 2003-10-06 | Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20031455A0 true FI20031455A0 (sv) | 2003-10-06 |
Family
ID=29225904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20031455A FI20031455A0 (sv) | 2003-10-06 | 2003-10-06 | Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070129313A1 (sv) |
EP (1) | EP1678196B1 (sv) |
JP (1) | JP2007507472A (sv) |
AT (1) | ATE404580T1 (sv) |
FI (1) | FI20031455A0 (sv) |
WO (1) | WO2005033124A1 (sv) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20031454A0 (sv) * | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiva somatostatinreceptor 1 och/eller 4 -agonister och -antagonister |
US20100004339A1 (en) * | 2003-10-06 | 2010-01-07 | Oy Juvantia Pharma Ltd. | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
WO2005082845A1 (en) * | 2004-02-27 | 2005-09-09 | Oy Juvantia Pharma Ltd | Novel therapies with somatostatin receptor agonists |
WO2005082844A1 (en) * | 2004-02-27 | 2005-09-09 | Oy Juvantia Pharma Ltd | Treatment of diseases by using a somatostatin receptor agonist |
CA2609161A1 (en) * | 2005-05-18 | 2006-11-23 | Siegfried Wurster | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
JP7343170B2 (ja) | 2017-05-12 | 2023-09-12 | ボード オブ トラスティーズ オブ ザ サザン イリノイ ユニバーシティ オン ビハーフ オブ サザン イリノイ ユニバーシティ エドワーズビル | 3,4,5-三置換-1,2,4-トリアゾールおよび3,4,5-三置換-3-チオ-1,2,4-トリアゾール、ならびにそれらの使用 |
US11912687B2 (en) | 2017-05-12 | 2024-02-27 | Board of Trustees of the Southern Illinois University | 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof |
JP7099717B2 (ja) * | 2019-09-30 | 2022-07-12 | 株式会社理研バイオ | ソマトスタチン受容体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2447314A1 (en) * | 2001-05-15 | 2002-11-21 | Atsuro Nakazato | Arginine derivatives |
WO2003026575A2 (en) * | 2001-09-24 | 2003-04-03 | Synaptic Pharmaceutical Corporation | Molecules specific for npff receptors and uses thereof |
WO2003026657A1 (en) * | 2001-09-24 | 2003-04-03 | Synaptic Pharmaceutical Corporation | Compounds for the treatment of pain |
JP2004155695A (ja) * | 2002-11-06 | 2004-06-03 | Taisho Pharmaceut Co Ltd | Mc4受容体に対するリガンド |
FI20031454A0 (sv) * | 2003-10-06 | 2003-10-06 | Juvantia Pharma Ltd Oy | Selektiva somatostatinreceptor 1 och/eller 4 -agonister och -antagonister |
-
2003
- 2003-10-06 FI FI20031455A patent/FI20031455A0/sv not_active Application Discontinuation
-
2004
- 2004-10-05 US US10/574,905 patent/US20070129313A1/en not_active Abandoned
- 2004-10-05 AT AT04767097T patent/ATE404580T1/de not_active IP Right Cessation
- 2004-10-05 WO PCT/FI2004/000583 patent/WO2005033124A1/en active IP Right Grant
- 2004-10-05 JP JP2006530316A patent/JP2007507472A/ja active Pending
- 2004-10-05 EP EP04767097A patent/EP1678196B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
EP1678196A1 (en) | 2006-07-12 |
JP2007507472A (ja) | 2007-03-29 |
EP1678196B1 (en) | 2008-08-13 |
WO2005033124A1 (en) | 2005-04-14 |
ATE404580T1 (de) | 2008-08-15 |
US20070129313A1 (en) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
BR0306150A (pt) | Composto, uso de um composto, e, composição farmacêutica | |
EA200301073A1 (ru) | N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора | |
NO20060154L (no) | Imidazolyl-derivater | |
TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
AU2006243987A8 (en) | Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof | |
ATE396993T1 (de) | Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
DE602004012858D1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
SG163585A1 (en) | Melanocortin receptor ligands | |
MXPA06012595A (es) | Analogos de amino-tetrazoles y metodos de uso. | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
WO2002010140A3 (en) | Imidazolyl derivatives | |
BRPI0516602A (pt) | composto, e, composição farmacêutica | |
TW200800982A (en) | Pyrazolopyridine derivatives as inhibitors of β-adrenergic receptor kinase 1 | |
FI20031455A0 (sv) | Sulfonylamino-peptidomimeter som är aktiva i förhållande till somatostatinreceptorsubtyper 4(SSTR4) och 1(SSTR1) | |
ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
ATE393781T1 (de) | Somatostatin analoge, deren radiomarkierte derivate und deren verwendung | |
MXPA05013149A (es) | Derivados de imidazol como antagonistas del receptor de glutamato. | |
EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
DK1644389T3 (da) | Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger | |
NO20084698L (no) | Metode for fremstilling av indazolyl-ureaer som inhiberer vanilloidreseptor subtype 1(VR1) | |
FI20031454A0 (sv) | Selektiva somatostatinreceptor 1 och/eller 4 -agonister och -antagonister | |
DE60139770D1 (de) | Hydantoin derivate mit affinität für somatostatin rezeptoren | |
DE60319989D1 (de) | Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |